Eli Lilly (NYSE: LLY) has transformed from a steady pharmaceutical giant into one of Wall Street’s standout growth ...

The percentage of overweight or obese adults prescribed GLP-1s jumped by almost 587% between 2019 and 2024, according to a ...

Health insurance plans are changing how they cover GLP-1 drugs for weight loss to rein in costs, forcing doctors and patients ...

The drug also isn't expected to have the same supply constraints as injectable GLP-1 drugs, which need specialized injection pens as well ... On the day of Eli Lilly's earnings report, CVS Health ...

Eli Lilly and Co. is suing an Indianapolis-based ... Zepbound and Mounjaro are sold in sterile, single-use auto-injector pens or in single-dose vials. However, in the latest complaint, Lilly ...

Eli Lilly weight loss drug ... Ozempic (semaglutide) is a brand-name injection pen used to treat type 2 diabetes. Meanwhile, Mounjaro (tirzepatide) is a brand-name subcutaneous injection pen ...

Eli Lilly began offering vials of the two lowest doses of Zepbound, which is typically sold in auto-injector pens, in August. Danish drugmaker Novo Nordisk will also offer home delivery of ...

NovoCare will supply all dosage strengths of Wegovy in single-dose injection pens that will be shipped ... Strong demand for both Wegovy and Eli Lilly’s Zepbound led to shortages of those ...

Eli Lilly said on Tuesday it has begun selling ... which is typically sold in auto-injector pens, to help increase availability. On Tuesday, it said it had also cut the prices for a month ...

Eli Lilly (NYSE:LLY) announced Tuesday it expanded ... to the price charged by the Indiana-based drugmaker for injector pen versions of the drug at those dose levels. The company has also reduced ...

That differs from single-dose autoinjector pens, the currently available form of all Zepbound doses, which patients can directly inject under their skin with the click of a button. Eli Lilly has ...